[Relevance of quality of life and treatment compliance measurement in patients with chronic open-angle glaucoma].
Chronic glaucoma is a severe disease that can induce blindness.Early diagnosis and symptomatic treatment reduce the risk of blindness. Treatment that will be started before the onset of clinical signs and will remain lifelong thereafter is troublesome, and therapeutic compliance is usually poor. Thus, quality of life (QOL) measurement in patients with chronic glaucoma has a particular purpose: to measure patients' perception of the disease and treatment in order to maintain good treatment compliance to ensure therapeutic management efficacy and to preserve visual function. No glaucoma-specific instrument is available in the medical and QOL literature. Various generic(SF-36, SF-20 and SIP) and specific(VAQ, VF-14, NEI-VFQ) QOL questionnaires,one glaucoma-specific symptomatic scale (GSS),and one treatment preference scale (COMTol) have been used to measure QOL in glaucoma patients. These instruments do not sufficiently measure the psychosocial dimension of the disease and the QOL impact of treatment. An instrument able to measure all dimensions needs to be developed in order to help ophthalmologists in the therapeutic management of their patients and to measure QOLin patients in the successive stages of the disease.
Baudouin
C
C
C.H.N.O des XV-XX, Paris.
Béchetoille
A
A
Bron
A
A
Denis
P
P
Nordmann
J P
JP
Renard
J P
JP
Rouland
J F
JF
Sellem
E
E
Rigeade
M C
MC
Arnould
B
B
D001294:Attitude to Health; D002908:Chronic Disease; D005902:Glaucoma, Open-Angle / Q000523:psychology* / Q000534:rehabilitation / Q000628:therapy*; D006801:Humans; D010349:Patient Compliance; D011788:Quality of Life; D015203:Reproducibility of Results; D012917:Social Adjustment; D011795:Surveys and Questionnaires